Analysis Salarius Pharmaceuticals Inc (SLRX)
6/3/2024
Analysis of Salarius Pharmaceuticals Inc (SLRX)
Salarius Pharmaceuticals Inc (SLRX) has been showing some volatility in its stock price over the past few days. The stock closed at $0.463 on May 31st, slightly lower than the previous day's close of $0.462.Key technical indicators such as the Relative Strength Index (RSI), Moving Average Convergence Divergence (MACD), and Moving Averages (MA) suggest mixed signals. The RSI is around 43.47, indicating a neutral sentiment. The MACD line is slightly below the signal line, with a negative MACD histogram, suggesting a bearish trend.
The stock has been trading below its Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA), indicating a downward trend.
Overall, the stock seems to be facing some selling pressure, with technical indicators pointing towards a potential bearish trend. Traders and investors may want to closely monitor the stock's price action and key support levels in the coming days.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance and payments, and other financing charges.
6. Investing activities include the sale and purchase of investments, capital expenditures, and other investing activities.
7. The company has been paying dividends and issuing short-term debt as part of its financing activities.
8. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that have contributed to its financial position over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS):1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. The EPS is expected to be higher than the $1.35 reported in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. Analysts are forecasting an increase in EPS compared to the $6.10 reported for the current year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The growth rate for the current quarter is estimated to be 5.1%.
2. Next Quarter: The growth rate for the next quarter is expected to be slightly higher at 5.2%.
3. Current Year: For the current year, the growth rate is projected to be 7.6%.
4. Next Year: The growth rate for the next year is forecasted to increase to 9.7%.
5. Past 5 Years (per annum): Over the past 5 years, the company has experienced a growth rate of approximately 20.1% per annum.
6. Next 5 Years (per annum): Looking ahead, analysts anticipate a growth rate of around 9.7% per annum for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rate expected in the upcoming periods compared to the past performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end being $164, the high end being $275, and the average forecast at $204.58. The current price of the security is $192.25, which is below the median and average forecast, indicating that there is some optimism among analysts for the security to increase in value.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, by the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results from October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The company's stock price summary includes beta, moving averages, and the range of its stock price over the past year.
Valuation metrics show metrics such as P/E ratio, PEG ratio, price to book, and enterprise value multiples. The market capitalization is also provided.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split information.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a need for cost management strategies.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Earnings before interest and taxes (EBIT) have shown an increasing trend, reaching $117.7 billion in 2023.
5. Net income has also been on the rise, reaching $97 billion in 2023.
6. The company has been able to maintain a consistent number of outstanding shares over the years.
7. Overall, the financial performance of the company seems to be improving, with increasing revenues and profitability.
MACD of SLRX
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
